Less Risk, More Speed -The New Blueprint for Bioconjugate Development: A Fireside Chat

Join this webinar to learn how an integrated CDMO+CRO model is transforming bioconjugate development by reducing risk and accelerating timelines from discovery to GMP supply. Discover actionable strategies and real-world insights to streamline your ADC and biologics programs while avoiding costly delays and late-stage failures.

You’ll leave with insights on:
– How an integrated development model reduces technical & operational risk across next-gen modalities
– Early development strategies that front-load risk identification & mitigation before it becomes costly
– Partner and technology selection criteria — what to look for and what to avoid
– Navigating the evolving regulatory landscape for novel bioconjugate modalities
– Fast-track execution strategies that compress the discovery-to-GMP timeline without compromising quality